Enanta Pharmaceuticals Q4 revenue rises, helped by higher sales of AbbVie's MAVYRET/MAVIRET - TradingView

Reuters | Nov. 17, 2025, 4:13 p.m. | Original
Enanta Pharmaceuticals Q4 revenue rises, helped by higher sales of AbbVie's MAVYRET/MAVIRET TradingView
Trump plans more steps to cut healthcare costs in coming weeks, senior White House official says - Reuters Radiant Logistics Announces Renewal Of Its Stock Repurchase Program - TradingView